Long-term echocardiographic Doppler monitoring of Hancock bioprostheses in the mitral valve position

Percutaneous closure of prosthetic paravalvular leaks: Case series and review

BACKGROUND

Paravalvular leaks (PVLs) are a well-recognized complication of prosthetic valve replacement. Most are asymptomatic and benign, but some may cause symptoms due to a large regurgitant volume or hemolysis. Medical therapy is palliative, while reoperation carries significant morbidity and mortality. Percutaneous transcatheter closure techniques, now routinely applied in the management of pathological cardiac and vascular communications, may be adaptable to PVL closure, potentially offer symptomatic relief.

METHODS

We reviewed our experience with attempted percutaneous closure of PVLs, using data from medical and procedural records.

RESULTS

Between 2001 and 2004, 14 procedures were performed in 10 patients, all under general anesthesia, with transesophageal and radiographic guidance. Mitral (9) and aortic (1) valve replacements were involved, both mechanical and bioprosthetic. A variety of devices were used, including atrial septal occluders, patent ductus arteriosus occluders, and coils (all of label use). Six had a single procedure, which was technically successful in four: in two, the PVL could not be crossed. Four underwent a second procedure, which was technically successful in three; in one the previously deployed device was dislodged necessitating urgent, but ultimately uneventful, surgical removal and leak repair. One patient had transient severe hemolysis, which resolved after 1 week. At 1-year follow-up (9/10 pts) three had died, five had sustained symptomatic improvement while 1 patient with a residual leak still required regular blood transfusions.

CONCLUSIONS

Percutaneous closure of PVLs is time-consuming but feasible in selected patients, with a reasonable degree of technical and clinical success. A second procedure may be necessary and a variety of complications can occur.

Over twenty-year follow-up of the standard Hancock porcine bioprosthesis implanted in the mitral position

BACKGROUND

To define the long-term results of 331 standard Hancock porcine bioprostheses implanted in the mitral position between 1973 and 1980.

METHODS

Of 331 patients (225 male patients, 68%), mean age 49+/-10 years (range 14 to 69 years), 88% were in New York Heart Association functional class III or IV and 77% were in atrial fibrillation. Follow-up time extended more than 20 years (mean 13.9 years, range 0.3 to 24.7 years) for a total of 4,601 patient-years.

RESULTS

Overall operative mortality was 6.3%. At 5, 10, 15, and 20 years, the actuarial survival rate of patients were 71%+/-2%, 46%+/-3%, 30%+/-3%, and 22%+/-2%, respectively. Actuarial estimates of freedom from structural valve deterioration were 95%+/-1%, 67%+/-3%, 32%+/-3%, and 14%+/-3%; from reoperation were 96%+/-1%, 72%+/-3%, 36%+/-4%, and 18%+/-4%; from thromboembolism were 89%+/-2%, 82%+/-3%, 74%+/-4%, and 51%+/-2%; and from anticoagulant-related hemorrhage were 98%+/-1%, 96%+/-1%, 91%+/-1%, and 86%+/-4%. Estimates of freedom from all valve-related mortality at 5, 10, 15, and 20 years were 89%+/-2%, 76%+/-3%, 64%+/-4%, and 48%+/-4%. Multivariate analysis showed younger age to be a significant risk factor for reoperation. Age at operation did not correlate with structural valve deterioration.

CONCLUSIONS

The long-term results with the standard Hancock bioprosthesis implanted in the mitral position appear satisfactory, particularly up to 15 years from implantation. Protection from stroke, anticoagulant hemorrhage, and endocarditis was good.

Serial Doppler Gradients Are Predictive of Future Bioprosthetic Valve Degeneration

Doppler echocardiography and color flow imaging are helpful techniques in evaluating the functional status of a bioprosthetic valve. The aim of this study was to determine whether serial Doppler gradients are predictive of future bioprosthetic valve degeneration. We performed serial echo-Doppler studies over a 6-year period (1988-1994) on 228 patients who had undergone mitral (n = 112) or aortic (n = 116) bioprosthetic valve implantation between 1973 and 1994. Thirty-nine mitral prostheses and 30 aortic prostheses became dysfunctional and required reoperation. A serial rise in mean gradient of 5 mmHg or more across the mitral valve and 25 mmHg or more across the aortic valve was significantly associated with increased valve degeneration (odds ratio 3.40 and 16.11 and 95% confidence intervals 1.31 and 8.80 and 13.6 and 72.13 for the mitral and aortic valve, respectively). Both aortic and mitral valves began to degenerate after 8 years. Serial echo-Doppler studies showed a rise in transvalvular gradients around the same time. Closer evaluation for prosthetic valve dysfunction should be considered in patients 8 or more years status post surgery, especially those with high transvalvular gradients.

Serial doppler echocardiographic evaluation of bioprosthetic valves in the tricuspid position

OBJECTIVES

This study sought to evaluate bioprosthetic valve dysfunction in the tricuspid position by serial Doppler echocardiography.

BACKGROUND

Few reports on the long-term results of tricuspid valve replacement with bioprosthetic valves are evaluated by serial Doppler echocardiography.

METHODS

Between September 1979 and December 1993, 95 patients underwent tricuspid valve replacement with bioprosthetic valves at our facility. Sixty patients who underwent serial Doppler echocardiographic examination at intervals of at least 2 years after operation were included in the final analysis. These patients were followed up from 1.5 to 13.0 years (mean 5.8 +/- 2.5).

RESULTS

The actuarial rates of freedom from bioprosthetic valve stenosis and regurgitation at 10 years were 46% and 51%, respectively. The prevalence of bioprosthetic valve stenosis and regurgitation increased progressively in a linear manner beginning 1 or 2 years after tricuspid valve replacement. Right heart failure developed during follow-up in 20 of the 25 patients with bioprosthetic valve dysfunction.

CONCLUSIONS

The long-term durability of bioprosthetic valves in the tricuspid position was substantially lower in our study than that reported in previous studies. Tricuspid bioprosthetic valve dysfunction increased progressively in a linear manner beginning 1 to 2 years after tricuspid valve replacement.